Associate Director, Patient Marketing
Cogent BiosciencesWaltham, Massachusetts, United States · Posted 2 months agoDescription
Who We Are:
Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing.
The Role: Cogent Biosciences is seeking an Associated Director of Patient Marketing to design and deliver a best-in-class, end-to-end patient experience for the launch of Bezuclastinib in Systemic Mastocytosis & Gastrointestinal Stromal (GIST) Tumors. Reporting to the Sr. Director of Patient Marketing, this individual will help shape how patients are identified, educated, activated, and supported throughout their disease and treatment journey. Serving as the internal champion for the patient voice, the role translates complex clinical data into meaningful, patient-centric resources and drives high-impact media strategies to reach those in need. In close collaboration with HCP marketing and patient services, this leader will help ensure a seamless transition from awareness to access and ongoing support. The ideal candidate brings deep rare disease and/or oncology expertise and a strong foundation in patient-centric marketing.
Responsibilities:
-
Responsibilities Patient Strategy
- Support the develop and execution of a comprehensive U.S. patient marketing strategy across the product lifecycle, including unbranded disease awareness and branded campaigns
- Maintain and continuously refine the patient journey by identifying new inflection points, emotional hurdles, and barriers to treatment through ongoing insights collection
- Support patient-focused market research, in collaboration with the market insights & patient advocacy teams, to ensure all brand messaging resonates with the lived experience of patients with systemic mastocytosis and GIST
Resource and Digital Ecosystem Development Lead the creation of patient-facing materials and partner closely with the HCP Marketing and Sales teams to ensure patient resources are effectively utilized by the field in the clinical setting
- Design and implement an integrated digital ecosystem (e.g., branded patient websites, paid search, social, CRM, programmatic) that supports education, engagement, activation, and treatment adherence
- Track foundational metrics/KPIs and optimize performance in real-time
- Develop and oversee data-driven omnichannel strategies for patients cross multiple disease states to ensure high-impact outreach and engagement, and a strong KPI-based evaluation and optimization
- Ensure omnichannel plans align with brand strategy and launch plans and support HCP teams with omnichannel needs
- Integrate innovations, including AI-enabled tools, to accelerate marketing outcomes
Leadership and Collaboration
- Lead the internal integration of patient insights across the organization, partnering with cross-functional teams to bridge the gap between clinical data and patient experience, ensuring a seamless and unified brand journey
- Partner with Patient Advocacy, Patient Services and Market Access teams to build messaging and support tools that address education, affordability, reimbursement, and treatment continuity
- Coordinate with the Patient Advocacy team to ensure brand strategies align with the broader goals of the Systemic Mastocytosis & GIST patient communities
Qualifications:
-
- Bachelor’s degree required; Advanced degree (e.g., PharmD, MBA) preferred
- Oncology and/or rare disease launch experience required
- 5+ years of experience in pharmaceutical, biotech, or healthcare marketing, with 2+ years of experience in patient marketing
- Proven success in digital patient marketing (web, social, SEO/SEM, CRM, and paid media strategy) and media planning and execution
- Deep understanding of the patient journey and emotional drivers of behavior in rare disease and/or oncology disease populations
- Experience collaborating with patient services (Patient Advocacy and PSP) to develop aligned messaging and support tools
- Demonstrated ability to thrive in a fast-paced biotech environment
- Travel required (up to 25%), including occasional weekends
- Location: Waltham, MA (surrounding areas) required
Knowledge And Skills
- Ability to build clear and differentiated patient-friendly messaging to convey clinical benefit
- Strong analytical and problem-solving skills, with the ability to leverage market research and performance data to inform decisions and optimize impact
- Demonstrated experience developing and executing omnichannel strategies across multiple audiences and touchpoints
- Strong project management and operational execution skills; able to manage multiple workstreams and launch-critical deadlines in a fast-paced environment
- Excellent communication, storytelling, and presentation skills—able to simplify complex clinical information for varied audiences
- Experience managing agencies/vendors, budgets, and complex project plans with strong operational rigor and attention to detail
- Strong understanding of MLR processes
- Strong cross-functional leadership skills, including the ability to influence without authority
Salary Range:
$195,000- $230,000 USD
Waltham, MA: Our headquarters is located in the Greater Boston life sciences community, with an open, collaborative office environment designed to support teamwork and connection. Employees benefit from convenient on-site amenities, including free on-site parking and gym facilities in the building.
Boulder, CO: Our Boulder location is home to Cogent’s discovery research organization and a key scientific hub with strong leadership based on site. Situated in the greater Denver-Boulder biopharmaceutical corridor, this office plays a central role in advancing our discovery efforts and pipeline.
Our Offer To You
At Cogent Biosciences, we offer a competitive salary, bonus, and ongoing stock awards, alongside a benefits package that sets us apart. We cover 100% of medical, dental, and vision premiums for you and your family, and help reduce out-of-pocket costs by funding up to 75% of in-network deductibles. Our benefits also include a 401(k) match with immediate vesting, generous paid time off, 12 weeks of fully paid parental leave, paid family and medical leave for all employees regardless of location, and company-paid short-term disability coverage for up to 20 weeks. Additional perks like wellness programs, tuition reimbursement, and inclusive family-forming support help you thrive at work and beyond.
We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need.
Similar jobs
Est. 222,500 USD
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib,…
Est. 222,500 USD
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib,…
Est. 215,000 USD
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib,…
Est. 170,000 USD
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib,…
Est. 200,000 USD
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib,…
Est. 192,500 USD
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib,…
Est. 97,680 USD
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib,…
Est. 177,500 USD
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib,…
Est. 102,500 USD
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib,…
Est. 225,000 USD
Who We Are: Cogent Biosciences is a publicly traded biotechnology company dedicated to developing precision therapies for genetically defined diseases. By leveraging validated biology and a rational drug discovery approa…
Est. 195,000 USD
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib,…
Est. 140,000 USD
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib,…
Est. 215,000 USD
How will your role help us transform hope into reality? The Associate Director, US Patient Marketing is a critical role responsible for shaping how the AYVAKIT (avapritinib) brand connects with patients and caregivers ac…
Est. 187,500 USD
Company introduction: Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. The Company is headquartered in London, UK, with a…
Est. 265,000 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Est. 167,600 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Est. 210,000 USD
Location: Jacksonville, FL; Tallahassee, FL; Gainesville, FL How will your role help us transform hope into reality? The Area Business Manager will contribute to a record-setting launch with AYVAKIT, build a new market t…
Est. 176,700 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Est. 200,050 USD
For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments…
Est. 140,000 USD
For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments…
Est. 140,000 USD
CareDx is a leading precision medicine diagnostics company advancing care in transplant, specialty oncology, and cell therapy. Through our innovative portfolio of molecular diagnostics, digital health solutions, AI-power…
Est. 140,000 USD
About GenScript Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop groundbreaki…
Est. 120,000 USD
About GenScript Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop groundbreaki…
Est. 214,369 USD
A Rare Opportunity to Shape the Future of Genomics Join a team of brilliant, passionate innovators determined to transform healthcare. At BillionToOne, we've built a category-defining, publicly traded company on Nasdaq w…
Est. 199,000 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 267,500 USD
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Te…
Est. 160,000 USD
Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company that focuses on innovative products that meet the needs of underserved patients. As an industry leader in providing unique, accessible, and hi…
Est. 160,000 USD
Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company that focuses on innovative products that meet the needs of underserved patients. As an industry leader in providing unique, accessible, and hi…
Est. 243,000 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Est. 226,000 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…